Literature DB >> 21917873

Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.

Jitske Tiemensma1, Adrian A Kaptein, Alberto M Pereira, Johannes W A Smit, Johannes A Romijn, Nienke R Biermasz.   

Abstract

CONTEXT AND
OBJECTIVE: Illness perceptions pertain to the beliefs patients develop about their illness, and these views are determinants of behavior directed at the illness. Illness perceptions are determinants of quality of life (QoL). QoL remains impaired in patients with biochemical control of acromegaly, but illness perceptions were never studied in these patients. AIM: The aim of the current study was to explore illness perceptions and their association with QoL in patients with long-term biochemical control of acromegaly.
DESIGN: This was a cross-sectional study.
SUBJECTS: We included patients with long-term biochemical control of acromegaly (n = 81), and compared them with Dutch reference populations: patients with acute pain (n=35) or chronic pain (n = 63), Cushing's syndrome (n = 52), chronic obstructive pulmonary disease (n = 171), and vestibular schwannoma (n = 80). Illness perceptions were evaluated using the Illness Perception Questionnaire Revised, and QoL was assessed with the Physical Symptoms Checklist, EuroQoL-5D, and AcroQoL.
RESULTS: Illness perceptions showed strong correlations with QoL. Patients after remission of acromegaly have a good understanding of their disease, but they experience a lack of personal control and are not likely to seek medical care compared with patients with acute disease (all P < 0.01).
CONCLUSION: Illness perceptions of patients after long-term remission of acromegaly are affected and strongly related to QoL. Patients reported more negative illness perceptions than patients with acute illness but more positive illness perceptions than patients with chronic diseases. Additional research is necessary to assess whether a self-management intervention might help in improving affected illness perceptions and thereby improve QoL.

Entities:  

Mesh:

Year:  2011        PMID: 21917873     DOI: 10.1210/jc.2011-1645

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission.

Authors:  Alberto M Pereira
Journal:  Endocrine       Date:  2015-09-08       Impact factor: 3.633

2.  Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

Authors:  Cornelie D Andela; Nicolasine D Niemeijer; Margreet Scharloo; Jitske Tiemensma; Shaaji Kanagasabapathy; Alberto M Pereira; Noëlle G A Kamminga; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

3.  Illness perceptions, risk perception and worry in SDH mutation carriers.

Authors:  L T van Hulsteijn; A A Kaptein; A Louisse; N R Biermasz; J W A Smit; E P M Corssmit
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

Review 4.  Update on quality of life in patients with acromegaly.

Authors:  Iris Crespo; Elena Valassi; Susan M Webb
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

5.  Perception of health and cognitive dysfunction in acromegaly patients.

Authors:  Iris Crespo; Susan M Webb
Journal:  Endocrine       Date:  2014-03-25       Impact factor: 3.633

6.  Impact of treatment satisfaction on quality of life of patients with acromegaly.

Authors:  Hasan Kepicoglu; Esra Hatipoglu; Irem Bulut; Ezgi Darici; Naz Hizli; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 7.  Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly.

Authors:  Federico Gatto; Claudia Campana; Francesco Cocchiara; Giuliana Corica; Manuela Albertelli; Mara Boschetti; Gianluigi Zona; Diego Criminelli; Massimo Giusti; Diego Ferone
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

8.  The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.

Authors:  Kenichi Yoshida; Hidenori Fukuoka; Ryusaku Matsumoto; Hironori Bando; Kentaro Suda; Hitoshi Nishizawa; Genzo Iguchi; Wataru Ogawa; Susan M Webb; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

9.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

10.  Impact of exercise on quality of life and body-self perception of patients with acromegaly.

Authors:  Esra Hatipoglu; Nuri Topsakal; Oya Erkut Atilgan; Nilufer Alcalar; Asiye Filiz Camliguney; Mutlu Niyazoglu; Hasan Birol Cotuk; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.